Brioschi et al. reported that AACT with three other abundant plasma proteins in patients with HF, namely, neuropilin-2, beta 2 microglobulin, and complement component C9, could discriminate patients with HF from healthy subjects with sufficient accuracy [29] and could be used as a diagnostic biomarker. This evidence concerns the gene C9 and hydrops fetalis.